In Southeast Asia, 36 percent of the drug samples tested were judged to be counterfeit, as were 20 percent of the drug samples in sub - Saharan Africa.
Dienvidaustrumāzijā par viltotiem tika atzīti 36 procenti pārbaudīto medikamentu paraugu, bet Subsahāras Āfrikā — 20 procenti.